| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
05.05.2014 EP 14166985
|
| (43) |
Date of publication of application: |
|
15.03.2017 Bulletin 2017/11 |
| (73) |
Proprietor: Novio TH B.V. |
|
6536 CL Nijmegen (NL) |
|
| (72) |
Inventor: |
|
- SALDEN, Martinus Hubertus Leonardus
NL-6536 CL Nijmegen (NL)
|
| (74) |
Representative: Life Science Patents B.V. |
|
Oxfordlaan 55
6229 EV Maastricht
6229 EV Maastricht (NL) |
| (56) |
References cited: :
WO-A1-2009/115612
|
WO-A2-03/050542
|
|
| |
|
|
- JOYCE JBC VAN BEERS ET AL: "ACPA fine-specificity profiles in early rheumatoid arthritis
patients do not correlate with clinical features at baseline or with disease progression",
ARTHRITIS RESEARCH AND THERAPY, BIOMED CENTRAL, LONDON, GB, vol. 15, no. 5, 1 October
2013 (2013-10-01), page R140, XP021165639, ISSN: 1478-6354, DOI: 10.1186/AR4322
- WALTHER J. VAN VENROOIJ ET AL: "Anti-CCP antibodies: the past, the present and the
future", NATURE REVIEWS RHEUMATOLOGY, vol. 7, no. 7, 7 June 2011 (2011-06-07), pages
391-398, XP055145475, ISSN: 1759-4790, DOI: 10.1038/nrrheum.2011.76
- SCHELLEKENS GG ET AL: "Citrulline is an essential constituent of antigenic determinant
recognized by rheumatoid arthritis-specific autoantibodies", JOURNAL OF CLINICAL INVESTIGATION,
AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, vol. 101, no. 1, 1 January 1998 (1998-01-01),
pages 273-281, XP002108877, ISSN: 0021-9738, DOI: 10.1172/JCI1316
- CATIMEL B ET AL: "Kinetics of the autologous red cell agglutination test", JOURNAL
OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 165,
no. 2, 15 October 1993 (1993-10-15), pages 183-192, XP023974634, ISSN: 0022-1759,
DOI: 10.1016/0022-1759(93)90344-7 [retrieved on 1993-10-15]
|
|
